Digital ophthalmoscope could put an end to unnecessary referrals and waiting lists

Article

A new digital ophthalmoscope could provide optometrists with the ability to email detailed eye maps of patients to specialist eye doctors.

A new digital ophthalmoscope could provide optometrists with the ability to email detailed eye maps of patients to specialist eye doctors.

Researchers at the University of Warwick, Keeler Optics, City University and University College London (UCL), UK have spent three years developing the ophthalmoscope, which uses a combination of specialist lens digital imaging and lighting technology. The result is a device which creates high resolution digital images that can be captured and recorded.

Professor Peter Bryanston-Cross, from the University of Warwick, has also been able to apply software that "stitches" together detailed map images to assemble the captured images from the ophthalmoscope - producing a highly detailed single picture of medical significance. It provides a map of the eye equal to the field of view and resolution of the large fundus cameras typically used in hospitals.

Previously, high street opticians have relied on notes and sketches when referring patients to eye clinics. With this technology, they would be able to create detailed eye images which could then be emailed to specialists, reducing patient referral and diagnosis times.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.